Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Practice Point
  • Published:

Is low-dose aspirin a safe and effective option for primary stroke prevention in patients with atrial fibrillation?

Nature Clinical Practice Cardiovascular Medicine volume 3, pages 248–249 (2006)Cite this article

boxed-textSato H et al. (2006) Low-dose aspirin for prevention of stroke in low-risk patients with atrial fibrillation: Japan Atrial Fibrillation Stroke Trial. Stroke 37: 447–451

Background

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Antithrombotic Trialists' Collaboration (2002) Collaborative meta-analysis of randomized trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high-risk patients. BMJ 324: 71–86

  2. Hart RG et al. (1999) Antithrombotic therapy to prevent stroke in patients with atrial fibrillation: a meta-analysis. Ann Intern Med 131: 492–501

    Article  CAS  Google Scholar 

  3. Aguilar MI and Hart RG (2006) Antiplatelet therapy for preventing stroke in patients with nonvalvular atrial fibrillation and no previous history of stroke or transient ischemic attacks: Cochrane Corner. Stroke 37: 274–275

    Article  Google Scholar 

  4. Stroke Prevention in Atrial Fibrillation Investigators (1991) The Stroke Prevention in Atrial Fibrillation Study: final results. Circulation 84: 527–539

  5. European Atrial Fibrillation Trial Study Group (1993) Secondary prevention in non-rheumatic atrial fibrillation after transient ischemic attack or minor stroke. Lancet 342: 1255–1262

  6. The Atrial Fibrillation Investigators (1997) The efficacy of aspirin in patients with atrial fibrillation: analysis of pooled data from three randomized trials. Arch Intern Med 157: 1237–1240

Download references

Acknowledgements

The synopsis was written by Hannah Camm, Associate Editor, Nature Clinical Practice.

Author information

Authors and Affiliations

  1. Department of Medicine, University of Texas Health Science Center, San Antonio, TX, USA

    Robert G Hart

  2. biostatistical consultant based in Minot, ND, USA

    Lesly A Pearce

Authors
  1. Robert G Hart
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Lesly A Pearce
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Robert G Hart.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hart, R., Pearce, L. Is low-dose aspirin a safe and effective option for primary stroke prevention in patients with atrial fibrillation?. Nat Rev Cardiol 3, 248–249 (2006). https://doi.org/10.1038/ncpcardio0543

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncpcardio0543

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing